Language
中文
2019-11-19
Gracell Announces Five Presentations at the Annual Meeting of American Society of Hematology (ASH)
2019-09-12
Gracell Announces Interim Readout of Investigation for First-in-class FasT CAR-19 in patients with Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia and Extension in Use of FasT CAR to Other Immune Cell Programs
2019-06-21
Gracell Data on Multi-center Investigation of FasT CAR-19 Thera Therapy Shows Positive First Impact in Patients with Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia
2019-04-23
Gracell Bio Announces FasT CAR-T, a Breakthrough Technology for Hematological Mailgnancies
2019-02-26
Gracell Biotechnologies Completes $85 Million Series B for Immune Cell Gene Therapies